USMJ Plans For WCVC To Lead Joint Cannabis Themed Restaurant Strategy
June 17 2019 - 12:05PM
InvestorsHub NewsWire
USMJ Plans For WCVC To Lead Joint
Cannabis Themed Restaurant Strategy
Dallas, TX -- June 17, 2019 --
InvestorsHub NewsWire -- North American Cannabis Holdings, Inc.
(USOTC:
USMJ) (“USMJ”) today issued an update on its plans with
West Coast Venture Group, Corp.
(WCVC)
(“WCVC”).
WCVC $3 Million In
Annual Revenue With $0.07 PPS and $0.20 PPS
Potential
WCVC is the owner and operator of Illegal
Burger operating in cannabis friendly Colorado and introducing
their very own cannabis infused menu. WCVC is a fully
reporting company with audited financials reporting over $3 million
in annual revenue. Based on a recent analysis published by
WCVC, on conventional market comparable valuations, WCVC can support a $0.20
PPS.
USMJ has piloted a concept restaurant
called The AmeriCanna Cafe. In a strategy to expand the
pilot, USMJ spun the AmeriCanna Cafe off into an independently
listed company, Priority Aviation, Inc. (USOTC: PJET). In
accordance with the spinoff deal, PJET is undergoing a name change
in conjunction with its new business direction.
Simultaneously, with the spinoff, USMJ entered into a partnership
with WCVC to advance the AmeriCanna Cafe restaurant
initiative. Based on WCVC’s momentum stemming from WCVC’s
management expertise in the restaurant industry, USMJ and PJET
management plan to give WCVC increased authority on the overall
AmeriCanna Cafe initiative. USMJ will provide logistics
services and PJET will work primarily as an investor on the
AmeriCanna Cafe initiative.
To learn more
visit www.USMJ.com
and www.GrowUSMJ.com.
Disclaimer/Safe
Harbor:
This news
release contains forward-looking statements within the meaning of
the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any
disease.
Steven
Rash
CEO
North American Cannabis Holdings, Inc.
info@aciconglomerated.com
+1-800-861-1350